Search - tctmd.com

Displaying 41 - 60 of 402

Sort: Relevancy | Date

Presentation TCT 2020

The PROSPECT ABSORB Trial: Randomized Evaluation of Vulnerable Plaque Treatment with Percutaneous Coronary Intervention

Presenter: Gregg Stone

October 14, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Presentation TCT 2020

Early and Late Outcomes of Left Main PCI: Insights From SYNTAX, PRECOMBAT, NOBLE, and EXCEL

Presenter: Gregg Stone

October 14, 2020

Presentation TCT 2020

TCT 434: Success, Safety, and Patency of the V-Wave Ventura Interatrial Shunt in Chronic Heart Failure

Presenter: Gregg Stone

October 14, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

Presentation TCT 2019

V-Wave for HFrEF and HFpEF

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

Presenter: Gregg Stone

September 28, 2019

News Conference News TCT 2019

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

Marcus A. Banks

September 28, 2019

Presentation TCT 2019

Late Benefits From BVS: Theory and Evidence

Presenter: Gregg Stone

September 28, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

Presentation TCT 2019

EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease

Presenter: Gregg Stone

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Presentation TCT 2019

TCT 2019 Linnemeier Young Investigator Award Presentation

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

TCT 7: Blinded Outcomes Assessment of Absorb Bioresorbable Scaffolds Implanted With Improved Technique: Two-year Results From the ABSORB IV Randomized Trial

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

Which Patients Are (and Are Not) Candidates for Intravenous Platelet Inhibition During PCI?

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

ABSORB 5-Year Pooled Analysis: Improving Very Late Outcomes of the Absorb Bioresorbable Scaffold in Coronary Artery Disease From 4 Randomized Trials

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

Welcome and Introduction

Presenter: Gregg Stone

September 26, 2019

Presentation TCT 2019

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Presenter: Gregg Stone

September 26, 2019

Advertisement

The PROSPECT ABSORB Trial: Randomized Evaluation of Vulnerable Plaque Treatment with Percutaneous Coronary Intervention

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Early and Late Outcomes of Left Main PCI: Insights From SYNTAX, PRECOMBAT, NOBLE, and EXCEL

TCT 434: Success, Safety, and Patency of the V-Wave Ventura Interatrial Shunt in Chronic Heart Failure

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

V-Wave for HFrEF and HFpEF

Transcatheter Mitral Valve Repair and Replacement Clinical Trial Designs After COAPT and MITRA-FR

EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG

Late Benefits From BVS: Theory and Evidence

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

EXCEL: 5-Year Outcomes From a Randomized Trial of PCI vs. CABG in Patients With Left Main Coronary Artery Disease

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

TCT 2019 Linnemeier Young Investigator Award Presentation

Update on CALM-II Trial (Endovascular Baroreflex Stimulation)

TCT 7: Blinded Outcomes Assessment of Absorb Bioresorbable Scaffolds Implanted With Improved Technique: Two-year Results From the ABSORB IV Randomized Trial

Which Patients Are (and Are Not) Candidates for Intravenous Platelet Inhibition During PCI?

Pivotal Transcatheter FMR Device Trials: Future Perspectives One Year After COAPT and MITRA-FR

ABSORB 5-Year Pooled Analysis: Improving Very Late Outcomes of the Absorb Bioresorbable Scaffold in Coronary Artery Disease From 4 Randomized Trials

Welcome and Introduction

Infarct Size Reduction: From the First FDA-Approved Therapy (SSO2) to Novel Approaches

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content